Ashley Hay, BSN, RN

Developing modern strategies to predict and accurately monitor treatment response remains an important piece of the clinical management puzzle.

The COVID-19 pandemic has brought about a currently interminable pause on in-person professional networking.

New guidelines from he American Society of Hematology for treating newly diagnosed acute myeloid leukemia in older patients recommend intensive antileukemic therapies over more conservative approaches.